文献速递糖尿病

2型糖尿病心血管结局试验的临床转化:表面所见之外还有更多或更少?

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?
PubMed 文献 · Diabetes Care · 2021-01-01

本文介绍随机对照试验(RCT)的基本原理,讨论相对风险(RR)与绝对风险(AR)所传达的不同信息,并以钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽1受体激动剂在2型糖尿病患者中的心血管结局试验为例,说明同时评估RR与AR变化有助于将研究结果明智地转化为临床判断,并建议了实用解释要点及受限平均生存时间这一替代方法。

要点

  • 阅读RCT结果前需应用批判性评价技能,避免误解和误用研究发现。
  • 相对风险与绝对风险传达不同信息,应同时评估以平衡转化研究结果。
  • 建议采用实用要点辅助解读试验内和跨试验报告,并提及受限平均生存时间替代方法。

核心结论

  • 同时评估相对风险和绝对风险的变化有助于将心血管结局试验结果明智地转化为临床判断。

研究设计与样本

  • 本文为方法学综述,介绍RCT基本原理,并以近期钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽1受体激动剂在2型糖尿病患者中的心血管结局试验为例进行阐释。

主要发现

  • 相对风险与绝对风险传达不同的信息,需同时评估以平衡转化研究结果。

临床怎么用

  • 阅读临床试验结果前应应用批判性评价技能,避免盲目接受结果和结论。
  • 解读试验内和跨试验报告时可参考本文建议的实用要点。
  • 可考虑使用受限平均生存时间作为获得治疗组与安慰剂组平均错过事件时间无偏估计的替代方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Randomized controlled trials (RCTs) have become the gold standard of clinical evidence and the staple of guided clinical practice. RCTs are based on a complex set of principles and procedures heavily strung by statistical analysis, primarily designed to answer a specific question in a clinical experiment. Readers of clinical trials need to apply critical appraisal skills before blindly accepting the results and conclusions of trials, lest they misinterpret and misapply the findings. We introduce the fundamentals of an RCT and discuss the relationship between relative risk (RR) and absolute risk (AR) in terms of the different information each conveys. The top results of some recent cardiovascular outcome trials using sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes are used to exemplify the merit of assessing both RR and AR changes for a balanced translation of findings into shrewd clinical judgment. We also suggest practical points to assist with a clinically useful interpretation of both within-trial and across-trial reports. Finally, we mention an alternative approach, namely, the restricted mean survival time, to obtaining unbiased estimates of the mean time of missed events in the treatment versus placebo arm for the duration of the trial.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ferrannini E, Rosenstock J. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care. 2021. PMID: 33608325. doi:10.2337/dc20-0913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。